CASI icon

CASI Pharmaceuticals
CASI

Overview Fund Trends Analyst Outlook Journalist POV

44 hedge funds and large institutions have $18.9M invested in CASI Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 14 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

64% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 14

Holders
44
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$253K
2
+$109K
3
+$78.5K
4
Citigroup
Citigroup
New York
+$59K
5
VF
Virtu Financial
New York
+$25.8K

Top Sellers

1
-$1.34M
2
-$1.06M
3
-$640K
4
Marshall Wace
Marshall Wace
United Kingdom
-$241K
5
AFM
Anson Funds Management
Texas
-$214K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$20K
27
$19K
28
$17K
29
$13K
30
$12K
31
$11K
32
$8K
33
$8K
34
$6K
35
$2K
36
$2K
37
$1.09K
38
$1K
39
$1K
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
1
2